Funko Inc. (NASDAQ: FNKO): Earnings are catching up while the stock bottoms, says Zacks, which named it as the Bull of the Day stock. The shares most recently closed at $16.25 and have a consensus price target of $24.89.
Goldman Sachs Group Inc. (NYSE: GS): Morgan Stanley upgraded the Wall Street powerhouse to Equal Weight from Underweight and has a $479 price target. The consensus target is $453.84. The last trade for Monday was reported at $389.30.
Hibbett Inc. (NASDAQ: HIBB): Baird upgraded the stock to Outperform from Neutral and has a $100 target price. The consensus target is $114.17. The last trade for Monday hit the tape at $73.59, which was up almost 7% for the day.
Insmed Inc. (NASDAQ: INSM): JPMorgan started coverage with an Overweight rating and a $45 target price. The consensus target is $53.44. The stock closed on Monday at $26.81.
Juniper Networks Inc. (NYSE: JNPR): Jefferies upgraded the shares to Buy from Hold and boosted the $28 price target to $42. The consensus target is $28.50. The stock closed on Monday at $31.45. The shares were up close to 4% in premarket trading.
Lennox International Inc. (NYSE: LII): Deutsche Bank raised its Hold rating to Buy with a $392 price target. The consensus target for the HVAC heavyweight is $316.64. The stock was last seen on Monday at $327.82, after rising close to 4% for the day.
Lulu’s Fashion Lounge Holdings Inc. (NASDAQ: LVLU): After the recent initial public offering, this stock has been hit hard, but it got some love as Goldman Sachs started coverage with a Buy rating and a huge $33 price target. Cowen started the shares at Outperform with a $21 target, while Jefferies began its coverage with a Buy rating and a $23 price objective. Monday’s closing print was $11.61, which was up almost 5% for the day.
Merck & Co. Inc. (NYSE: MRK): Guggenheim downgraded the pharmaceutical giant to Neutral from Buy. The shares have traded in a 52-week range of $68.44 to $91.40 and have a $95.74 consensus price objective. The final trade for Monday was reported at $73.42.
Moderna Inc. (NASDAQ: MRNA): Cowen started coverage of the vaccine giant with a Neutral rating. Over the past year, the shares have traded in a wide range of $102.66 to $497.49, and they have a $301 consensus price target. The stock pulled back almost 14% on Monday to close at $265.43.
Nektar Therapeutics Inc. (NASDAQ: NKTR): Goldman Sachs maintained a Neutral rating on the shares and has a $25 price target. The consensus target is slightly higher at $25.86. The final Monday trade was reported at $11.86, which was up close to 10% for the day.
Omnicell Inc. (NASDAQ: OMCL): Wells Fargo resumed coverage with an Overweight rating and a $203 target price. The consensus price objective is $186.33. The final trade on Monday was reported at $180.27.
Sponsored: Tips for Investing
A financial advisor can help you understand the advantages and disadvantages of investment properties. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you. If you’re ready to find an advisor who can help you achieve your financial goals, get started now.
Investing in real estate can diversify your portfolio. But expanding your horizons may add additional costs. If you’re an investor looking to minimize expenses, consider checking out online brokerages. They often offer low investment fees, helping you maximize your profit.